Alyeska Investment Group
SHACU

Alyeska Investment Group’s SCP & CO Healthcare Acquisition Company Unit SHACU Stock Holding History

Alyeska Investment Group’s Portfolio SHACU Stock Details SHACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-250,000
Closed -$2.49M – 975
2021
Q1 		$2.49M Buy
+250,000
New +$2.55M 0.03% 432

Other funds holding SHACU

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

Alyeska Investment Group's SHACU Position: Q2 2021 in Review

Alyeska Investment Group sold out of SCP & CO Healthcare Acquisition Company Unit (SHACU) in Q2 2021, closing a stake of 250,000 shares — an estimated $2.49M sold.

Alyeska Investment Group first reported a position in SHACU in Q1 2021 and held it in 1 quarter. The position peaked at $2.49M in Q1 2021. 43 funds tracked by Wall St. Rank hold SHACU as of Q2 2021.

  • Alyeska Investment Group reported no remaining SCP & CO Healthcare Acquisition Company Unit position as of Q2 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 250,000 SCP & CO Healthcare Acquisition Company Unit shares in Q2 2021, an estimated $2.49M.
  • Alyeska Investment Group first reported a position in SCP & CO Healthcare Acquisition Company Unit in Q1 2021 and held it in 1 quarter.
  • Alyeska Investment Group's SCP & CO Healthcare Acquisition Company Unit position peaked at $2.49M in Q1 2021.
  • 43 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Unit as of Q2 2021.

Based on Alyeska Investment Group's 13F filing for Q2 2021, filed 16 Aug 2021.